Wednesday, May 27, 2020

Pharma Reviews: BDR Pharmaceuticals move on Remdesivir clone irks Gilead

The Indian company had submitted its application for manufacturing the Covid-19 drug to the Drug Controller General of India (DCGI) last week. By.
Read more: BDR Pharmaceuticals move on Remdesivir clone irks Gilead